ATLASRegenxbio (RGNX) earnings date: Nov 5, 2026
Regenxbio (RGNX) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, before the open. Analysts expect EPS of -$1.35.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on RGNX
| Last price | $7.13 (-1.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.2% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Regenxbio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Regenxbio reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Regenxbio. You can switch it off at any time.
Alert me before RGNX reportsFree to start. Creating an account takes under a minute.
Notify me when Regenxbio reports
Track RGNX free Add Regenxbio to a free ATLAS watchlist and see its next report date in one place.
RGNX earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.35 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +89.1% |
| Average move around a report | ±13.0% (last 5) |
| Sector | Healthcare · Biotechnology |
Regenxbio earnings history: last 5 reports
Regenxbio last reported on Aug 6, 2026: EPS of $0.43 against an estimate of -$0.11 (+490.9% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.11 | $0.43 | +490.9% | Beat | +2.1% |
| May 14, 2026 | -$1.41 | -$1.72 | -22.0% | Miss | -43.0% |
| Mar 5, 2026 | -$0.84 | -$1.30 | -54.8% | Miss | -5.4% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | -13.3% |
| Nov 7, 2025 | $0.60 | $0.69 | +15.0% | Beat | -1.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for RGNX
See the fair value, the probability range and the earnings history of Regenxbio on its ATLAS page.
Regenxbio (RGNX) stock analysisPlans from €3.99 a month.
Regenxbio earnings: frequently asked questions
When does Regenxbio (RGNX) report earnings?
Regenxbio is scheduled to report on Thursday, November 5, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for RGNX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.35 per share (USD). Estimates can change before the report.
How often does RGNX beat earnings estimates?
Of its last 5 reports with a recorded result, Regenxbio beat the EPS estimate 3 times; the average surprise was +89.1%. Past results do not predict the next one.
How much does RGNX move around earnings?
Over its last 5 reports the stock moved an average of 13.0% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Regenxbio beat earnings estimates last quarter?
Regenxbio last reported on Aug 6, 2026: EPS of $0.43 against an estimate of -$0.11 (+490.9% surprise), a beat.
How much does RGNX usually move in a day?
On a normal trading day the ATLAS model puts RGNX’s one-day range at about ±4.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer